Skip to main content
OpenTrials
Completed

NCT Number: NCT04755049

The Chinese Version of the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form Questionnaire, Patient Self-report Section: A Cross-cultural Adaptation and Validation Study

Background: The patient self-report section of the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASESp) is one of the most validated and reliable assessment tools. This study aimed to establish a validated Chinese version of ASESp (ASESp-CH).

Methods: A clinical prospective study was performed. Following the guidelines of forward-backward translation and cross-cultural adaptation, a Chinese version of ASESp was established. Patients older than 18 years with shoulder disorders were included. Patients who could not complete test-retest questionnaires within the interval of 7-30 days and patients who received interventions were excluded. Intraclass correlation (ICC) was calculated for test- retest reliability, whereas internal consistency was determined by Cronbach value. Construct validity was evaluated by comparing the corresponding domains between the ASESp-CH and a validated Chinese version of 36-Item Short Form Health Survey (SF-36).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Shoulder Pain Arthralgia Joint Diseases Musculoskeletal Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

National Cheng Kung University Hospital

Tainan, 70428, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • [1] patients' age ≥ 18 years
  • [2] patients with clear insights
  • [3] patients with any shoulder disorders
  • [4] patients who are able to speak and write in Chinese
  • [5] patients who completed the questionnaires twice at an interval of 7 days to 30 days.

Exclusion criteria

  • [1] the patient could not complete all of ASESp-CH and SF-36 questionnaires
  • [2] the test-retest interval was less than 7 days or more than 30 days
  • [3] the patient received interventional procedures, such as shoulder injections or surgery, during the test-retest interval

Treatment and study plan

The Chinese version of the American Shoulder and Elbow Surgeons standardized shoulder assessment form questionnaire

Diagnostic Test

The Chinese version of the American Shoulder and Elbow Surgeons standardized shoulder assessment form questionnaire

Primary outcomes

  1. The Chinese version of the American Shoulder and Elbow Surgeons standardized shoulder assessment form questionnaire

    Time frame: The questionaire was completed at 7 days before the index surgery.

    American Shoulder and Elbow Surgeons (ASES) Assessment Form, ranging from 0-100. The higher score indicates better shoulder function.

Sponsors and collaborators

Lead sponsor

National Cheng-Kung University Hospital

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Feb 15, 2021
Registry last updated
Sep 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.